510(k) K813395
K813395 is an FDA 510(k) premarket notification submitted by Helena Laboratories for the device "CELLULOSE ACETATE-CITRATE AGAR HEMOGLO". The FDA issued a decision of Substantially Equivalent on December 31, 1981. The device falls under product code JBD (System, Analysis, Electrophoretic Hemoglobin), a Class II device regulated under 21 CFR 864.7440. Helena Laboratories has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- December 31, 1981
- Date Received
- December 4, 1981
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, Analysis, Electrophoretic Hemoglobin
- Device Class
- Class II
- Regulation Number
- 864.7440
- Review Panel
- HE
- Submission Type